Answer
In the absence of compatibility studies, the Baxter Healthcare Ltd eribulin 0.44 mg/mL solution for injection product must not be mixed with other medicinal products except those mentioned in section 6.6.
Sources for this answer
- Eribulin Baxter 0.44 mg/mL solution for injectionBaxter Healthcare Ltd · emc · SmPC §6.2 Incompatibilities · Version 2Document updated
Sources checked